Medicare Enrolled
Dr. Edgardo Soto De La Rosa, M.D.
Pulmonary Disease · Port Charlotte, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Soto De La Rosa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Soto De La Rosa?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Soto De La Rosa
Dr. Edgardo Soto De La Rosa is a pulmonary disease specialist in Port Charlotte, FL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Soto De La Rosa performed 5,469 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Soto De La Rosa received a total of $15,401 from 54 pharmaceutical and/or device companies across 805 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Soto De La Rosa is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 6% volume in FL
$15,401 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 115041 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗5,469
Medicare services
Top 6% in FL for pulmonary disease
Not available
Unique patients (not deduplicated)
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,193 | $94 | $163 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,018 | $96 | $140 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
488 | $37 | $86 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
429 | $64 | $115 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
422 | $170 | $339 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
238 | $134 | $217 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
235 | $63 | $90 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
196 | $32 | $73 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
196 | $41 | $98 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
134 | $123 | $250 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
103 | $20 | $62 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
102 | $13 | $30 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
97 | $25 | $51 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
95 | $28 | $106 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
83 | $81 | $163 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
80 | $75 | $342 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
77 | $132 | $220 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
71 | $41 | $70 |
| Smoking cessation counseling, more than 10 minutes Intensive counseling session focused on helping patients quit smoking and tobacco use, lasting more than 10 minutes. |
57 | $28 | $35 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
56 | $15 | $20 |
| Lung cancer screening counseling visit A visit to discuss the need for lung cancer screening using a low-dose CT scan. This service is used to determine eligibility and facilitate shared decision making. |
29 | $29 | $50 |
| Overnight continuous oxygen level test This test measures oxygen levels in the blood continuously overnight using a device attached to the ear or finger. |
23 | $19 | $63 |
| Bronchoscopy with ultrasound and lymph node sampling A procedure using a scope and ultrasound to examine the airways and collect tissue samples from three or more lymph nodes. |
18 | $197 | $500 |
| Lung biopsy via endoscope, 1 lobe A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination. |
16 | $60 | $400 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
13 | $51 | $95 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$15,401
Total received (2018-2024)
Avg $2,200/year across 7 years
Top 14% in FL for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
805
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,541
2023
$1,868
2022
$2,160
2021
$2,009
2020
$1,531
2019
$2,735
2018
$2,557
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$905
GlaxoSmithKline, LLC.
$447
Regeneron Healthcare Solutions, Inc.
$288
Takeda Pharmaceuticals U.S.A., Inc.
$164
Actelion Pharmaceuticals US, Inc.
$162
Insmed, Inc.
$133
Bayer Healthcare Pharmaceuticals Inc.
$89
GENZYME CORPORATION
$55
Grifols USA, LLC
$53
Electromed, Inc.
$51
Amgen Inc.
$47
United Therapeutics Corporation
$41
Axsome Therapeutics, Inc.
$30
Azurity Pharmaceuticals, Inc.
$22
Ambu Inc.
$19
Paratek Pharmaceuticals, Inc.
$18
Baxter Healthcare
$17
Top 3 companies account for 64.5% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,916
AstraZeneca Pharmaceuticals LP
$2,753
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,673
Actelion Pharmaceuticals US, Inc.
$1,056
Regeneron Healthcare Solutions, Inc.
$784
Mylan Specialty L.P.
$598
Insmed, Inc.
$556
Medical Device Business Services, Inc.
$507
Sunovion Pharmaceuticals Inc.
$479
Genentech USA, Inc.
$314
Grifols USA, LLC
$295
Paratek Pharmaceuticals, Inc.
$295
Bayer HealthCare Pharmaceuticals Inc.
$283
Gilead Sciences, Inc.
$209
Takeda Pharmaceuticals U.S.A., Inc.
$207
United Therapeutics Corporation
$206
Shire North American Group Inc
$195
GENZYME CORPORATION
$181
Ethicon Inc.
$176
Circassia Pharmaceuticals Inc
$161
Bayer Healthcare Pharmaceuticals Inc.
$141
Covidien LP
$120
Amgen Inc.
$115
Baxter Healthcare
$110
Electromed, Inc.
$92
CSL Behring
$77
Advanced Respiratory, Inc
$74
Novartis Pharmaceuticals Corporation
$55
JAZZ PHARMACEUTICALS INC.
$50
Vanda Pharmaceuticals Inc.
$48
Mallinckrodt LLC
$48
Harmony Biosciences LLC
$47
La Jolla Pharmaceutical Company
$46
Merck Sharp & Dohme LLC
$39
Veran Medical Technologies, Inc.
$38
Nabriva Therapeutics, plc
$38
Allergan Inc.
$38
ANI Pharmaceuticals, Inc.
$34
Mallinckrodt Enterprises LLC
$33
Axsome Therapeutics, Inc.
$30
Chiesi USA, Inc.
$28
Mallinckrodt Hospital Products Inc.
$25
BOSTON SCIENTIFIC CORPORATION
$24
Vapotherm Inc
$24
HARMONY BIOSCIENCES LLC
$22
Intuitive Surgical, Inc.
$22
Azurity Pharmaceuticals, Inc.
$22
Apria Healthcare LLC
$21
Ambu Inc.
$19
Merck Sharp & Dohme Corporation
$18
Boston Scientific Corporation
$18
Olympus America Inc.
$17
Philips Electronics North America Corporation
$16
Breathe Technologies, Inc.
$11
Top 3 companies account for 47.7% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · 1.8mm OD · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AVYCAZ · Adempas · Always-On Tip Tracked Forceps · Arikayce · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CLEVIPREX · CUVITRU · DIFICID · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Da Vinci Surgical System · Dymista · EXPECT · Esbriet · FARXIGA · FASENRA · GENERAL THROMBECTOMY · GIAPREZA · GLASSIA · HETLIOZ · HORIZANT · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Kcentra · LIFE2000 · LONHALA MAGNAIR · Life 2000 Ventilation System · MONARCH · Medela · Monarch Platform · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PURIFIED CORTROPHIN GEL · Perforomist · Precision Flow · Prolastin-C · Prolastin-C Liquid · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Serrated Cup · Spin · Sunosi · SuperDimension · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · UTIBRON NEOHALER · Utibron · Wakix · XOLAIR · XYREM · Xenleta · Xolair · YUPELRI · Yupelri
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
9
County median income
$66,154
Nearest hospital to ZIP centroid (approximate)
Adventhealth Port Charlotte
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Soto De La Rosa is a clinical cardiology specialist, with above-average Medicare volume (top 6% in FL), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Soto De La Rosa experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Soto De La Rosa performed 1,193 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Soto De La Rosa receive payments from pharmaceutical companies?
Yes. Dr. Soto De La Rosa received a total of $15,401 from 54 companies across 805 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Soto De La Rosa's costs compare to other pulmonary diseases in Port Charlotte?
Dr. Soto De La Rosa's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Soto De La Rosa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Port Charlotte
Browse pulmonary diseases in Port Charlotte ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in FL
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in FL
Which FL pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology